Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Symptomatic medication use in multiple sclerosis.

G Brichetto1, M Messmer Uccelli, G L Mancardi

  • 1Department of Neurological Sciences and Vision, University of Genova, Via De Toni 5, Genova, Italy. gian@brichetto.com

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indirect Costs Related to Productivity Loss, Work-Related Quality of Life, and Resource Utilization in Workers with Multiple Sclerosis.

Journal of occupational rehabilitation·2026
Same author

Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024
Same author

Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis.

Multiple sclerosis and related disorders·2024
Same author

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal of medical economics·2023
Same author

Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study.

Journal of neurology·2023
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Symptomatic treatments for multiple sclerosis (MS) are frequently prescribed for pain and spasticity, but less so for bladder dysfunction and fatigue. Further research into MS symptom management is needed.

Area of Science:

  • Neurology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a significant neurological condition with extensive research, yet symptomatic therapy often receives limited focus.
  • Understanding patient needs requires evaluating current medication prescription patterns for MS symptoms.

Purpose of the Study:

  • To assess the frequency of symptomatic medication prescriptions for major multiple sclerosis symptoms.
  • To identify potential gaps in the management of common MS-related symptoms.

Main Methods:

  • A cross-sectional epidemiological survey was conducted in Genoa, Italy.
  • Structured interviews were administered to 665 patients with multiple sclerosis.

Main Results:

  • 37% of patients used symptomatic medications; pain (28%) and spasticity (27%) were most treated.

Related Experiment Videos

  • Bladder dysfunction (8%) and fatigue (3%) were less frequently treated with medication.
  • 12% of patients were on medication for non-MS-related reasons.

    • Conclusions:

    • Medication is commonly prescribed for MS-related pain and spasticity, suggesting these symptoms are recognized.
    • Under-treatment of bladder dysfunction and fatigue in MS patients may warrant further investigation.
    • The findings highlight a need for more clinical trials focused on effective symptomatic therapies for multiple sclerosis.